1 of 1
Story summary
- The UK Health Department issued a statutory instrument letting the health secretary override NICE in a drug-pricing deal with U.S. President Donald Trump.
- Global Justice Now and Just Treatment call the rule an unlawful power grab and will seek judicial review while former health secretary Andrew Lansley says it breaches the Health and Social Care Act 2012.
- MPs decry secrecy and missing impact assessment.
